| legislation, drug | Laws concerned with manufacturing, dispensing, and marketing of drugs. (12 Dec 1998) |
|---|
| drug-drug interaction | The effects that occur when two or more drugs are used together. Such effects include changes of absorption in the digestive tract, changes in rate of the drugs' breakdown in the liver, new or enhanced side effects and changes in the drugs' activity. (09 Oct 1997) |
|---|---|
| legislation | The enactment of laws and ordinances and their regulation by official organs of a nation, state, or other legislative organization. It refers also to health-related laws and regulations in general or for which there is no specific heading. (12 Dec 1998) |
| legislation, dental | Laws and regulations pertaining to the field of dentistry, proposed for enactment or recently enacted by a legislative body. (12 Dec 1998) |
| legislation, food | Laws and regulations concerned with industrial processing and marketing of foods. (12 Dec 1998) |
| legislation, hospital | Laws and regulations concerning hospitals, which are proposed for enactment or enacted by a legislative body. (12 Dec 1998) |
| legislation, medical | Laws and regulations, pertaining to the field of medicine, proposed for enactment or enacted by a legislative body. (12 Dec 1998) |
| legislation, nursing | Laws and regulations, pertaining to the field of nursing, proposed for enactment by a legislative body. (12 Dec 1998) |
| legislation, pharmacy | Laws and regulations, pertaining to the field of pharmacy, proposed for enactment or enacted by a legislative body. (12 Dec 1998) |
| legislation, veterinary | Laws and regulations, pertaining to the field of veterinary medicine, proposed for enactment or enacted by a legislative body. (12 Dec 1998) |
| abnormalities, drug-induced | Congenital abnormalities caused by medicinal substances or drugs of abuse given to or taken by the mother, or to which she is inadvertently exposed during the manufacture of such substances. The concept excludes abnormalities resulting from exposure to non-medicinal chemicals in the environment. (12 Dec 1998) |
| activity, drug | A measure of the physiological response a drug produces in the body. A less active drug produces less response (and visa versa). (12 Dec 1998) |
| addictive drug | Any drug that creates a certain degree of euphoria and has a strong potential for addiction. (05 Mar 2000) |
| adverse drug reaction reporting systems | Systems developed for collecting reports from government agencies, manufacturers, hospitals, physicians, and other sources on adverse drug reactions. (12 Dec 1998) |
| akathisia, drug-induced | Motor restlessness with sensations of quivering and an urge to move about constantly resulting from the use of certain drugs, such as neuroleptic drugs, which affect the extrapyramidal region of the brain. This differs from dyskinesia, drug-induced in that long-term antipsychotic drug exposure is significantly correlated with the increased prevalence of akathisia while there is no such correlation with dyskinesia. The primary observable distinction between tardive akathisia and dyskinesia appears to be in the repetitive, stereotypy of the dyskinesic movements (lip smacking, for example), while akathisia is associated with anxiety, restlessness, and agitation (psychomotor agitation). (12 Dec 1998) |
| antineoplastic drug | A drug that stops or slows the maturation and spread of tumour cells (benign or malignant). (09 Oct 1997) |